CYCLOSPORINE Side Effects

6956945-1 | Alternaria Infection, Epstein-barr Virus Infection, Folliculitis, Fungal Skin Infection, Heart Transplant Rejection, Myocarditis, Opportunistic Infection, Phaehyphomycosis, Purulence
on Aug 12, 2010 Female patient from UNITED STATES , 45 years of age, was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: alternaria infection, epstein-barr virus infection, folliculitis, fungal skin infection, heart transplant rejection, myocarditis, opportunistic infection, phaehyphomycosis, purulence. Cyclosporine dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6955312-4 | Pneumocystis Jiroveci Pneumonia
Patient was taking Cyclosporine (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia on Aug 24, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with dermatomyositis and. Cyclosporine dosage: 200 Mg, Daily. During the same period patient was treated with PREDNISOLONE (60 Mg, Daily) (View Prednisolone Review and Prednisolone Label ).

6955283-0 | Aplastic Anaemia, Gene Mutation Identification Test Positive, Infection
Adverse event was reported on Aug 17, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: ) was diagnosed with aplastic anaemia and. Location: JAPAN , child 7 years of age, After Cyclosporine was administered, patient had the following side effects: aplastic anaemia, gene mutation identification test positive, infection (What is infection?). During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN (RABBIT) (Unk) (View Antilymphocyte Immunoglobulin (rabbit) Review and Antilymphocyte Immunoglobulin (rabbit) Label ).

6955271-4 | Abdominal Pain, Plasma Cells Increased, Plasmacytosis, Pyrexia, White Blood Cell Count Increased
on Aug 17, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with aplastic anaemia and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), plasma cells increased, plasmacytosis, pyrexia, white blood cell count increased. Cyclosporine dosage: Unk. During the same period patient was treated with DEXAMETHASONE (40mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.


6955007-7 | Aortic Stenosis, Basedow's Disease, Cardiac Murmur, Excessive Ocular Convergence, Hyperthyroidism
on Aug 11, 2010 Male patient from UNITED STATES , 68 years of age, was treated with Cyclosporine (View Usage). Patient had the following side effects: aortic stenosis, basedow's disease, cardiac murmur, excessive ocular convergence, hyperthyroidism. Cyclosporine dosage: Injection Nos. During the same period patient was treated with IMURAN (View Imuran Review and Imuran Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6955003-X | Mycosis Fungoides, Recurrent Cancer, Renal Failure
Patient was taking Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: mycosis fungoides, recurrent cancer, renal failure on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with immunosuppression, renal transplant and. Cyclosporine dosage: Injection Nos. During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6945872-1 | Haptoglobin Decreased, Plasmapheresis, Red Blood Cell Abnormality, Still's Disease Adult Onset, Thrombocytosis, Thrombotic Microangiopathy
Adverse event was reported on Aug 16, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: ) was diagnosed with still's disease adult onset and. Location: JAPAN , 24 years of age, Patient experienced the following unwanted or unexpected effects: haptoglobin decreased, plasmapheresis, red blood cell abnormality, still's disease adult onset, thrombocytosis, thrombotic microangiopathy. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NSAID'S (Unk) (View Nsaid's Review and Nsaid's Label ).

6945870-8 | Anaemia, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Haemolysis, Small-for-size Liver Syndrome, Thrombotic Thrombocytopenic Purpura
on Aug 16, 2010 Male patient from JAPAN , 54 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Cyclosporine (View Usage). Patient had the following side effects: anaemia, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, haemolysis, small-for-size liver syndrome, thrombotic thrombocytopenic purpura. Cyclosporine dosage: .

6945021-X | Condition Aggravated, Metastases To Lymph Nodes, Plasmacytoma, Stem Cell Transplant
on Aug 16, 2010 Female patient from JAPAN , 48 years of age, was diagnosed with poems syndrome and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: condition aggravated, metastases to lymph nodes, plasmacytoma, stem cell transplant. Cyclosporine dosage: Unk. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6945019-1 | Convulsion, Headache, Hypertension, Restlessness, Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, headache (What is headache?), hypertension, restlessness, reversible posterior leukoencephalopathy syndrome on Aug 16, 2010 from JAPAN Additional patient health information: Female patient , child 11 years of age, was diagnosed with systemic lupus erythematosus and. Cyclosporine dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ).

6945002-6 | Bone Pain, Colectomy, Colitis Ulcerative, Disease Progression, Erythema, Hypercoagulation, Neutrophilia, Oedema Peripheral
Adverse event was reported on Aug 16, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: 2 Mg/kg/d) was diagnosed with colitis ulcerative and. Location: IRELAND , 34 years of age, Patient had the following side effects: bone pain, colectomy, colitis ulcerative, disease progression, erythema, hypercoagulation, neutrophilia, oedema peripheral. During the same period patient was treated with HYDROCORTISONE (100 Mg, Qid) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6942975-2 | Condition Aggravated, Lung Infection Pseudomonal, No Therapeutic Response, Pseudomonal Sepsis
on Aug 13, 2010 Female patient from JAPAN , 43 years of age, was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: condition aggravated, lung infection pseudomonal, no therapeutic response, pseudomonal sepsis. Cyclosporine dosage: . Patient was hospitalized.

6940844-5 | Hallucination, Visual Impairment
on Aug 24, 2010 Male patient from UNITED STATES , weighting 158.1 lb, was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual impairment. Cyclosporine dosage: 125mg Iv. Patient was hospitalized.

6938961-9 | Acute Respiratory Distress Syndrome, Decreased Appetite, Fatigue, Histiocytosis Haematophagic, Immune Reconstitution Syndrome, Lung Disorder, Nausea, Pseudomonas Infection, Pyrexia
Patient was taking Cyclosporine (View Usage). Patient had the following side effects: acute respiratory distress syndrome, decreased appetite, fatigue, histiocytosis haematophagic, immune reconstitution syndrome, lung disorder, nausea (What is nausea?), pseudomonas infection, pyrexia on Aug 16, 2010 from SPAIN Additional patient health information: Male patient , 44 years of age, was diagnosed with histiocytosis haematophagic, tuberculosis (What is tuberculosis?), ankylosing spondylitis (What is ankylosing spondylitis?), immune reconstitution syndrome and. Cyclosporine dosage: 100-150 Mg/ Day. During the same period patient was treated with ETHAMBUTOL (NGX) (2 G/day) (View Ethambutol (ngx) Review and Ethambutol (ngx) Label ), ISONIAZID (300 Mg/day) (View Isoniazid Review and Isoniazid Label ), METHYLPREDNISOLONE 4MG TAB (60 Mg/day) (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), PREDNISONE (NGX) (70 Mg/day) (View Prednisone (ngx) Review and Prednisone (ngx) Label ), PYRAZINAMIDE (1750 Mg/day) (View Pyrazinamide Review and Pyrazinamide Label ), RIFAMPICIN (NGX) (600 Mg/day) (View Rifampicin (ngx) Review and Rifampicin (ngx) Label ), INFLIXIMAB (5 Mg/day, Over 2 Hrs) (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6938723-2 | Extrapyramidal Disorder, Muscle Rigidity, Parkinsonism, Tremor
Adverse event was reported on Aug 13, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: Unk) was diagnosed with liver transplant (What is liver transplant?) and. Location: SPAIN , 80 years of age, After Cyclosporine was administered, patient had the following side effects: extrapyramidal disorder, muscle rigidity, parkinsonism, tremor.

6938717-7 | Bradykinesia, Extrapyramidal Disorder, Parkinsonism, Tremor
on Aug 13, 2010 Male patient from SPAIN , 64 years of age, was diagnosed with pemphigoid and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: bradykinesia, extrapyramidal disorder, parkinsonism, tremor. Cyclosporine dosage: .

6938709-8 | Alternaria Infection, Epstein-barr Virus Infection, Heart Transplant Rejection, Lesion Excision, Myocarditis, Phaehyphomycosis
on Aug 13, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Cyclosporine (View Usage). Patient had the following side effects: alternaria infection, epstein-barr virus infection, heart transplant rejection, lesion excision, myocarditis, phaehyphomycosis. Cyclosporine dosage: Unk. During the same period patient was treated with MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), ITRACONAZOLE (200 Mg, Bid) (View Itraconazole Review and Itraconazole Label ), POSACONAZOLE (View Posaconazole Review and Posaconazole Label ). Patient was hospitalized.

6938689-5 | Extrapyramidal Disorder, Gait Disturbance, Parkinsonism
Patient was taking Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: extrapyramidal disorder, gait disturbance, parkinsonism on Aug 13, 2010 from SPAIN Additional patient health information: Male patient , 71 years of age, was diagnosed with liver transplant (What is liver transplant?) and. Cyclosporine dosage: .

6937086-6 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Aug 18, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: 200 Mg/day) . Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia.

6936375-9 | Anuria, Circulatory Collapse, Flank Pain, Kidney Enlargement, Lung Infiltration, Multi-organ Failure, Nephrectomy, Pyrexia, Respiratory Failure
on Aug 12, 2010 Female patient from GERMANY , 23 years of age, was diagnosed with acute graft versus host disease, immunosuppression, aspergillosis and was treated with Cyclosporine (View Usage). Patient had the following side effects: anuria, circulatory collapse, flank pain, kidney enlargement, lung infiltration, multi-organ failure, nephrectomy, pyrexia, respiratory failure. Cyclosporine dosage: . During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CASPOFUNGIN (Unk) (View Caspofungin Review and Caspofungin Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ).

6935302-8 | Gene Mutation, Infection
on Aug 02, 2010 Female patient from JAPAN , child 7 years of age, was diagnosed with aplastic anaemia and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: gene mutation, infection (What is infection?). Cyclosporine dosage: . During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN (RABBIT) (Unk) (View Antilymphocyte Immunoglobulin (rabbit) Review and Antilymphocyte Immunoglobulin (rabbit) Label ).

6935199-6 | Anaemia, Asthenia, Brain Oedema, Cardiomegaly, Dilatation Ventricular, Dyspnoea, Endocardial Fibrosis, Epstein-barr Virus Associated Lymphoproliferative Disorder, Epstein-barr Virus Infection
Patient was taking Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, brain oedema, cardiomegaly, dilatation ventricular, dyspnoea, endocardial fibrosis, epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection on Aug 16, 2010 from ITALY Additional patient health information: Male patient , 52 years of age, was diagnosed with heart transplant (What is heart transplant?) and. Cyclosporine dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6935149-2 | Megacolon
Adverse event was reported on Aug 16, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: ) . Location: NETHERLANDS , 63 years of age, Patient had the following side effects: megacolon. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6934938-8 | Asthenia, Bicytopenia, Cerebrovascular Accident, Cerebrovascular Spasm, Feeling Cold, Hypoaesthesia Facial
on Aug 11, 2010 Female patient from NETHERLANDS , 48 years of age, was diagnosed with aplastic anaemia, serum sickness and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: asthenia, bicytopenia, cerebrovascular accident, cerebrovascular spasm, feeling cold, hypoaesthesia facial. Cyclosporine dosage: 350 Mg, Bid. During the same period patient was treated with PREDNISONE (60 Mg, Qd) (View Prednisone Review and Prednisone Label ), CIPROFLOXACIN (500 Mg, Bid) (View Ciprofloxacin Review and Ciprofloxacin Label ), FLUCONAZOLE (200 Mg, Qd) (View Fluconazole Review and Fluconazole Label ), ANTI THYMOCYTE GLOBULIN NOS (15 Mg/kg, Qd) (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ). Patient was hospitalized.

6931339-3 | Blood Lactate Dehydrogenase Increased, Small-for-size Liver Syndrome, Thrombotic Thrombocytopenic Purpura
on Aug 04, 2010 Male patient from JAPAN , 54 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, small-for-size liver syndrome, thrombotic thrombocytopenic purpura. Cyclosporine dosage: .

6927399-6 | Type I Hypersensitivity
Patient was taking Cyclosporine (View Usage). Patient had the following side effects: type i hypersensitivity on Aug 09, 2010 from THAILAND Additional patient health information: Female patient , child 2 years of age, was diagnosed with systemic lupus erythematosus and. Cyclosporine dosage: . During the same period patient was treated with ASPARAGINASE (800u Tiw At Wk 2 And 3) (View Asparaginase Review and Asparaginase Label ).

6926192-8 | Thrombotic Microangiopathy
Adverse event was reported on Aug 02, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: Dosage Not Stated) . Location: ITALY , 59 years of age, After Cyclosporine was administered, patient had the following side effects: thrombotic microangiopathy. During the same period patient was treated with TICLOPIDINE HCL (Dosage Not Stated) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MESALAZINE (Dosage Not Stated) (View Mesalazine Review and Mesalazine Label ), MYCOPHENOLATE SODIUM (Dosage Not Stated) (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ). Patient was hospitalized.

6923129-2 | Convulsion, Diabetes Insipidus, Failure To Thrive, Haemorrhage Intracranial, Multi-organ Failure, Sepsis
on Jul 23, 2010 Male patient from UNITED STATES , 14 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, diabetes insipidus (What is diabetes insipidus?), failure to thrive, haemorrhage intracranial, multi-organ failure, sepsis (What is sepsis?). Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), MESNA (View Mesna Review and Mesna Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6923124-3 | Acute Chest Syndrome, Ataxia, Convulsion, Pneumonia
on Jul 23, 2010 Male patient from UNITED STATES , child 4 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with Cyclosporine (View Usage). Patient had the following side effects: acute chest syndrome, ataxia (What is ataxia?), convulsion, pneumonia (What is pneumonia?). Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ). Patient was hospitalized.

6923097-3 | Acute Graft Versus Host Disease In Liver, Chronic Graft Versus Host Disease, Cytomegalovirus Viraemia, Leukoencephalopathy, Pneumonia Pneumococcal, Septic Shock, Staphylococcal Infection
Patient was taking Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: acute graft versus host disease in liver, chronic graft versus host disease, cytomegalovirus viraemia, leukoencephalopathy, pneumonia pneumococcal, septic shock, staphylococcal infection (What is staphylococcal infection?) on Jul 23, 2010 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, was diagnosed with prophylaxis against graft versus host disease and. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESNA (View Mesna Review and Mesna Label ).

6923096-1 | Chronic Graft Versus Host Disease, Encephalitis, Leukoencephalopathy
Adverse event was reported on Jul 23, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: ) was diagnosed with prophylaxis against graft versus host disease and. Location: UNITED STATES , child 7. years of age, Patient experienced the following unwanted or unexpected effects: chronic graft versus host disease, encephalitis (What is encephalitis?), leukoencephalopathy. During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESNA (View Mesna Review and Mesna Label ).

6923095-X | Anaemia Haemolytic Autoimmune, Herpes Zoster, Premature Menopause, Reversible Posterior Leukoencephalopathy Syndrome
on Jul 23, 2010 Female patient from UNITED STATES , child 10 years of age, was diagnosed with prophylaxis against graft versus host disease, convulsion prophylaxis and was treated with Cyclosporine (View Usage). Patient had the following side effects: anaemia haemolytic autoimmune, herpes zoster, premature menopause, reversible posterior leukoencephalopathy syndrome. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MESNA (View Mesna Review and Mesna Label ).

6922950-4 | Acute Graft Versus Host Disease In Intestine, Acute Graft Versus Host Disease In Liver, Acute Graft Versus Host Disease In Skin, Chronic Graft Versus Host Disease, Fungal Test Positive, Inflammation, Lung Disorder, Multi-organ Failure, Renal Disorder
on Aug 10, 2010 Female patient from FRANCE , 38 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, chronic graft versus host disease, fungal test positive, inflammation, lung disorder, multi-organ failure, renal disorder. Cyclosporine dosage: Unk. During the same period patient was treated with MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6922948-6 | Graft Versus Host Disease
Patient was taking Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: graft versus host disease on Aug 11, 2010 from TURKEY Additional patient health information: Male patient , 56 years of age, was diagnosed with graft versus host disease and. Cyclosporine dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6919946-5 | Condition Aggravated, Plasmacytoma
Adverse event was reported on Aug 02, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: Unk) was diagnosed with poems syndrome and. Location: JAPAN , 48 years of age, Patient had the following side effects: condition aggravated, plasmacytoma. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ).

6919056-7 | Acinetobacter Infection, Bacterial Toxaemia, Condition Aggravated, Keloid Scar, Pustular Psoriasis, Pyrexia, Rash Pustular
on Jul 28, 2010 Female patient from BRAZIL , 18 years of age, was diagnosed with pustular psoriasis and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: acinetobacter infection, bacterial toxaemia, condition aggravated, keloid scar, pustular psoriasis, pyrexia, rash pustular. Cyclosporine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), INFLIXIMAB (5 Mg/kg) (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6917465-3 | Abdominal Pain, Plasma Cells Increased, Pyrexia, White Blood Cell Count Increased
on Aug 02, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with aplastic anaemia and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), plasma cells increased, pyrexia, white blood cell count increased. Cyclosporine dosage: Unk. Patient was hospitalized.

6917448-3 | Duodenitis Haemorrhagic, Gastric Ulcer Haemorrhage
Patient was taking Cyclosporine (View Usage). Patient had the following side effects: duodenitis haemorrhagic, gastric ulcer haemorrhage on Aug 03, 2010 from GERMANY Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with renal transplant and. Cyclosporine dosage: Unk. During the same period patient was treated with MYFORTIC (Unk) (View Myfortic Review and Myfortic Label ), NO TREATMENT RECEIVED NOMED (Unk) (View No Treatment Received Nomed Review and No Treatment Received Nomed Label ), URBASON (Unk) (View Urbason Review and Urbason Label ). Patient was hospitalized.

6916488-8 | Burkholderia Cepacia Complex Infection, Burkholderia Cepacia Complex Sepsis, Colectomy, Colon Cancer Metastatic, Cough, Haemodialysis, Lung Abscess, Lung Infiltration, Lung Wedge Resection
Adverse event was reported on Aug 04, 2010 by a Female patient taking Cyclosporine (View Usage) (Dosage: 5 Mg/kg, Bid) was diagnosed with lung transplant (What is lung transplant?) and. Location: CANADA , 24 years of age, After Cyclosporine was administered, patient had the following side effects: burkholderia cepacia complex infection, burkholderia cepacia complex sepsis, colectomy, colon cancer metastatic, cough, haemodialysis, lung abscess, lung infiltration, lung wedge resection. During the same period patient was treated with AZATHIOPRINE (1 Mg/kg/day) (View Azathioprine Review and Azathioprine Label ), PREDNISONE (0.5 Mg/kg/day) (View Prednisone Review and Prednisone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ). Patient was hospitalized.

6915518-7 | Chronic Graft Versus Host Disease, Cytomegalovirus Viraemia, Deafness Neurosensory, Premature Menopause
on Jul 23, 2010 Female patient from UNITED STATES , 16 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: chronic graft versus host disease, cytomegalovirus viraemia, deafness neurosensory, premature menopause. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ANTITHYMOCYTE IMMUNOGLOBULIN (View Antithymocyte Immunoglobulin Review and Antithymocyte Immunoglobulin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESNA (View Mesna Review and Mesna Label ).

6915505-9 | Acute Graft Versus Host Disease In Intestine, Platelet Count Decreased
on Jul 23, 2010 Male patient from UNITED STATES , child 9. years of age, was diagnosed with graft versus host disease, convulsion and was treated with Cyclosporine (View Usage). Patient had the following side effects: acute graft versus host disease in intestine, platelet count decreased. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), MESNA (View Mesna Review and Mesna Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6915032-9 | Acute Graft Versus Host Disease In Intestine, Chronic Graft Versus Host Disease
Patient was taking Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: acute graft versus host disease in intestine, chronic graft versus host disease on Jul 23, 2010 from UNITED STATES Additional patient health information: Female patient , child 2. years of age, was diagnosed with graft versus host disease, convulsion prophylaxis and. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MESNA (View Mesna Review and Mesna Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6914948-7 | Aortic Stenosis, Binocular Eye Movement Disorder, Cardiac Murmur, Hyperthyroidism
Adverse event was reported on Jul 24, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: aortic stenosis, binocular eye movement disorder, cardiac murmur, hyperthyroidism. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), IMURAN (View Imuran Review and Imuran Label ).

6914833-0 | Abdominal Pain, Anaemia, Anisocytosis, Asthenia, Colitis, Diarrhoea Haemorrhagic, Pyrexia, Thrombotic Microangiopathy
on Jul 30, 2010 Male patient from ITALY , 59 years of age, was diagnosed with renal transplant and was treated with Cyclosporine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, anisocytosis, asthenia, colitis, diarrhoea haemorrhagic, pyrexia, thrombotic microangiopathy. Cyclosporine dosage: . During the same period patient was treated with TICLOPIDINE (NGX) (View Ticlopidine (ngx) Review and Ticlopidine (ngx) Label ), MYCOPHENOLATE SODIUM (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), MESALAZINE (Unk) (View Mesalazine Review and Mesalazine Label ). Patient was hospitalized.

6914705-1 | Acute Graft Versus Host Disease In Intestine, Acute Graft Versus Host Disease In Liver, Acute Graft Versus Host Disease In Skin, Anaemia Haemolytic Autoimmune
on Jul 23, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, anaemia haemolytic autoimmune. Cyclosporine dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ANTITHYMOCYTE (View Antithymocyte Review and Antithymocyte Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ), MESNA (View Mesna Review and Mesna Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6911262-0 | Blood Creatine Phosphokinase Increased, Blood Creatinine Increased
Patient was taking Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood creatinine increased on Jul 29, 2010 from SWITZERLAND Additional patient health information: Male patient , 29 years of age, was diagnosed with systemic lupus erythematosus and. Cyclosporine dosage: 100 Mg, Bid. During the same period patient was treated with PLAQUENIL (200 Mg, Bid) (View Plaquenil Review and Plaquenil Label ).

6909569-6 | Diabetic Enteropathy, Malabsorption, Nephropathy Toxic, Renal Impairment, Urine Output Decreased
Adverse event was reported on Jul 09, 2010 by a Male patient taking Cyclosporine (View Usage) (Dosage: Unk) was diagnosed with renal transplant and. Location: JAPAN , 68 years of age, Patient had the following side effects: diabetic enteropathy, malabsorption, nephropathy toxic, renal impairment, urine output decreased.

6909507-6 | Convulsion, Encephalitis, Reversible Posterior Leukoencephalopathy Syndrome
on Jul 26, 2010 Male patient from UNITED STATES , child 7 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cyclosporine (View Usage). After Cyclosporine was administered, patient had the following side effects: convulsion, encephalitis (What is encephalitis?), reversible posterior leukoencephalopathy syndrome. Cyclosporine dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6909506-4 | Anaemia Haemolytic Autoimmune, Convulsion, Herpes Zoster, Ovarian Failure, Reversible Posterior Leukoencephalopathy Syndrome
on Jul 26, 2010 Female patient from UNITED STATES , child 10 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with Cyclosporine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, convulsion, herpes zoster, ovarian failure, reversible posterior leukoencephalopathy syndrome. Cyclosporine dosage: Unk. During the same period patient was treated with MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6909504-0 | Convulsion, Cytomegalovirus Viraemia, Pneumonia Pneumococcal, Reversible Posterior Leukoencephalopathy Syndrome, Septic Shock, Staphylococcal Infection
Patient was taking Cyclosporine (View Usage). Patient had the following side effects: convulsion, cytomegalovirus viraemia, pneumonia pneumococcal, reversible posterior leukoencephalopathy syndrome, septic shock, staphylococcal infection (What is staphylococcal infection?) on Jul 26, 2010 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, was diagnosed with prophylaxis against transplant rejection and. Cyclosporine dosage: Unk. During the same period patient was treated with PREDNISONE TAB (Unk) (View Prednisone Tab Review and Prednisone Tab Label ).